About Us

Hepatitis B and C Public Policy Association asbl

In April 2009 a group of leading European scientists, professors, public health experts and patient advocates created the Hepatitis B and C Summit Conferences Association as a Luxembourg-based not-for-profit Association (association sans but lucratif). The Association aimed primarily to deliver a summit conference on Hepatitis B and C in Europe, which was held in Brussels in October 2010 under the auspices of the Belgian EU Presidency.

The Association acknowledges with grateful thanks the support of the European Association for the Study of the Liver (EASL), the European Centre for Disease Prevention and Control (ECDC), the European Commission’s Directorate-General for Health and Consumers (DG SANCO), the European Monitoring Centre for Drugs and Drug Addiction (EMDCCA), the European Liver Patients Association (ELPA), the Viral Hepatitis Prevention Board (VHPB), the World Health Organisation – Europe (WHO-Europe) and the World Hepatitis Alliance (WHA) in its past activities.

Hepatitis B&C Public Policy Association is a founding member of the ACHIEVE coalition (Associations Collaborating on Hepatitis to Immunize and Eliminate the Viruses in Europe) which calls on the EU to take action to eliminate hepatitis B and C in Europe by 2030.
The Association’s work in the field of viral hepatitis B and C will continue to be developed in collaboration with the stakeholders mentioned above.

In June 2011 the Association’s name was changed to Hepatitis B and C Public Policy Association to reflect the broader, continuing activities of the Association. 

Financial contributions received in support of the Association’s activities are made directly to the Association’s Luxembourg bank account, and are disbursed at the discretion of its Directors. The current Sponsors of Hepatitis B&C Public Policy Association are: Gilead Sciences, AbbVie and MSD.

The auditors to the Association are Grant Thornton Audit & Assurance, 13B, rue de Bitbourg L- 1273 Luxembourg.
The Directors and members of the Association ensure and uphold its independence from its sponsors and other external partners.

Meet The Directors & Members of the Association

Co-Chairs

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Prof. Angelos Hatzakis MD PhD

Professor of Epidemiology and Preventive Medicine Head, National Retrovirus Reference Centre Director, Department of Hygiene, Epidemiology & Medical Statistics Athens University Medical School, Greece

Prof. Rafael Esteban MD

Liver Unit, Department of Internal Medicine, Vall d’Hebron University Hospital, Barcelona, Spain.

Prof. Heiner Wedemeyer MD

Treasurer

Prof. George V. Papatheodoridis MD PhD

National and Kapodistrian University of Athens Medical School, Greece

Members

Prof. Maria Buti

Liver Unit, Department of Internal Medicine, Vall d’Hebron University Hospital, Barcelona, Spain

Dr. Manuel Carballo

Executive Director, International Centre for Migration and Health (ICMH), Geneva, Switzerland

Prof. Laurent Castera

Department of Hepatology Hôpital Beaujon, AP-HP INSERM U773, University of Paris-VII, Clichy, France

Prof. Massimo Colombo

Head, Liver Center for Translational Research, IRCCS Humanitas, Milan, Italy
Chairman of the EASL International Liver Foundation, Geneva, Switzerland.

Prof. Antonio Craxi

Director, Gastroenterology and Internal Medicine University of Palermo, Italy

Prof. Gamal Esmat MD 

Professor of Hepatogastroenterology & Infectious Diseases Past Vice President of Cairo University, Egypt Egyptian Nile Award in Science 2016 State Merit Award in Medical Science 2010 WHO STAC Member Past President of International Association for Study of Liver Diseases

Prof. David Goldberg

Health Protection Scotland Centre for Virus Research Glasgow, Scotland

Prof. Harry Janssen

Head, UHN Liver Clinic, Toronto Western Hospital, Canada

Mr. George Kalamitsis

Chair, Hellenic Patients Association “Prometheus”, Athens, Greece.

Prof Jeffrey V. Lazarus

Associate Professor, University of Barcelona
Associate Researcher, ISGlobal, Hospital Clínic, University of Barcelona

Dr. Ricardo Baptista Leite 

Member of  Portuguese Parliament – Head of Public Health – Medical Doctor – University Professor -Public Health Advocate

Prof. Patrick Marcellin

Service d’Hépatologie, Hôpital Beaujon, APHP University of Paris, France

Prof. Mojca Maticic

Head of the Viral Hepatitis Unit and Head of the STI Outpatient Service at the Clinic for Infectious Diseases and Febrile Illnesses, University Medical Centre in Ljubljana, Slovenia

Prof. Markus Peck-Radosavljevic

 Professor of Medicine Chair, Dept. of Internal Medicine and Gastroenterology (IMuG) Hepatology, Endocrinology, Rheumatology and Nephrology Centralized Emergency Service (ZAE) Klinikum Klagenfurt am Wörthersee Klagenfurt, Austria

BIOG
 

Dr. Homie Razavi

Managing Director of the CDA Foundation, a non-profit organization dedicated to hepatitis elimination

BIOG
 

Prof. Nurdan Tozun

Vice Rector, Acibadem University Acibadem Kozyatagi Hospital Dept of Gastroenterology Istanbul, Turkey.

Prof. Pierre van Damme

Viral Hepatitis Prevention Board (VHPB) Vaccine and Infectious Disease Institute, Antwerp, Belgium

Dr. Su H Wang

Medical Director of the Center for Asian Health at Saint Barnabas Medical Center.

Dr. Zobair M. Younossi

Chairman, Department of Medicine, Inova Fairfax Medical Campus. He is also Professor of Medicine, Virginia Commonwealth University, Inova Campus and Affiliate Professor of Biomedical Sciences at George Mason University.

Affiliated Members

Nikos Dedes

President, Association of People Living with HIV in Greece ‘Positive Voice’ Greece.
BIOG